GB0722289D0 - Appetite suppression - Google Patents

Appetite suppression

Info

Publication number
GB0722289D0
GB0722289D0 GBGB0722289.6A GB0722289A GB0722289D0 GB 0722289 D0 GB0722289 D0 GB 0722289D0 GB 0722289 A GB0722289 A GB 0722289A GB 0722289 D0 GB0722289 D0 GB 0722289D0
Authority
GB
United Kingdom
Prior art keywords
appetite suppression
appetite
suppression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0722289.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntaxin Ltd
Original Assignee
Syntaxin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntaxin Ltd filed Critical Syntaxin Ltd
Priority to GBGB0722289.6A priority Critical patent/GB0722289D0/en
Publication of GB0722289D0 publication Critical patent/GB0722289D0/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
GBGB0722289.6A 2007-11-14 2007-11-14 Appetite suppression Ceased GB0722289D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB0722289.6A GB0722289D0 (en) 2007-11-14 2007-11-14 Appetite suppression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0722289.6A GB0722289D0 (en) 2007-11-14 2007-11-14 Appetite suppression

Publications (1)

Publication Number Publication Date
GB0722289D0 true GB0722289D0 (en) 2007-12-27

Family

ID=38896239

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0722289.6A Ceased GB0722289D0 (en) 2007-11-14 2007-11-14 Appetite suppression

Country Status (1)

Country Link
GB (1) GB0722289D0 (en)

Similar Documents

Publication Publication Date Title
GB0702608D0 (en) Aeroengine
EP2212908A4 (en) Fin-jfet
DE602008005470D1 (en) Imidazopyridinone
EP2160187A4 (en) Spiroindalones
AP2010005314A0 (en) Nanodispersian
EP2211752A4 (en) Biopulp
GB0722289D0 (en) Appetite suppression
DE602008004135D1 (en) Triphenylmethan- und xanthenpigmente
GB0700595D0 (en) Holecutter
GB0701068D0 (en) Suppression
IL205311A0 (en) An improved appetite suppressant
AU3952P (en) FLOCHRDEF Chrysocephalum apiculatum
AU3642P (en) TAS100 Dianella tasmanica
AU3606P (en) Jaywick xTriticosecale
AU3613P (en) LS005A01 Leucospermum cuneiforme
AU3595P (en) Goldust Strobilanthes anisophyllus
AU3646P (en) TAS300 Dianella tasmanica
AU3702P (en) DarwinGold Dianella ensifolia
GB0718494D0 (en) MUulti-function extension
GB0715691D0 (en) Hair-we-grwo extension
IL182392A0 (en) Reverser
AU315253S (en) Microphone
GB0717120D0 (en) Microphone
GB0722992D0 (en) Microphones
AU320760S (en) Cutsaw

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)